Investing Ideas
/
South Korean Pharmaceuticals & Biotech Undervalued Small Caps

South Korean Pharmaceuticals & Biotech Undervalued Small Caps

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Undervalued Small Caps

1 companies

Hugel

Market Cap: ₩2.7t

Develops and manufactures biopharmaceuticals in South Korea and internationally.

A145020

₩253,500.00

4.1%

-12.0%